NDC 50090-5677-00 - Alendronate Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-5677
- Requested NDC
- 50090-5677-00
- Package NDCs from labels
- 50090-5677-0, 50090-5677-1, 50090-5677-00
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-02-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Alendronate Sodium - A-S Medication Solutions | A-S Medication Solutions | 2026-02-13 | Human Prescription Drug Label |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-5677-0 | Alendronate Sodium | 4 in 1 BLISTER PACK | TABLET | 4 | 11 | |
| 50090-5677-0 | Alendronate Sodium | 1 in 1 CARTON | TABLET | 1 | 11 | |
| 50090-5677-1 | Alendronate Sodium | 3 in 1 CARTON | TABLET | 3 | 11 | |
| 50090-5677-1 | Alendronate Sodium | 4 in 1 BLISTER PACK | TABLET | 4 | 11 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-5677 | ALENDRONATE SODIUM TABLET [A-S MEDICATION SOLUTIONS] | 9 | Current NDC, Legacy NDC, 4 package rows | 20231117_eeb65442-6b3c-485c-9c5d-9cf40df4451e.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-5677-0 | EA - Each | 50090-5677 | 66e8429a-87c5-469d-9fbd-eea9aab73407 | 1 | 2022-10-06 |
| 50090-5677-1 | EA - Each | 50090-5677 | d33797ea-b6a4-4310-9e6e-b12b41d1df52 | 1 | 2022-10-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ALENDRONATE SODIUM | ALENDRONATE SODIUM | REMEDYREPACK INC. | c7e470d6-508e-466e-a78d-060bbbc9745c | 2026-07-03 | Warnings, Adverse reactions | 904396 2UY4M2U3RA |
| ALENDRONATE SODIUM | ALENDRONATE SODIUM | NuCare Pharmaceuticals,Inc. | 54d6543d-4239-58b1-e054-00144ff88e88 | 2026-06-23 | Warnings, Adverse reactions | 904431 2UY4M2U3RA |
| ALENDRONATE SODIUM | ALENDRONATE SODIUM | REMEDYREPACK INC. | c4358ba7-1bf8-4b0a-9407-5ac279d04555 | 2026-06-22 | Warnings, Adverse reactions | 904431 2UY4M2U3RA |
| Alendronate Sodium | ALENDRONATE SODIUM | Rising Pharma Holdings, Inc. | ffdd2496-d253-419b-85a6-8c615f7545f1 | 2026-06-12 | Warnings, Adverse reactions | ANDA090124 64980-342 904396 904431 904419 ae2e410c-e759-4879-9b18-aba62f096312 ffdd2496-d253-419b-85a6-8c615f7545f1 2UY4M2U3RA |
| Alendronate Sodium | ALENDRONATE SODIUM | NorthStar Rx LLC | 4323d3aa-cbb0-41e2-aba7-7a94a0516993 | 2026-06-12 | Warnings, Adverse reactions | ANDA090124 904396 904431 904419 2UY4M2U3RA |
| Alendronate Sodium | ALENDRONATE SODIUM | A-S Medication Solutions | d52cf007-5775-4dea-9f43-b1907b6ffe81 | 2026-05-22 | Warnings, Adverse reactions | ANDA090124 904431 2UY4M2U3RA |
| Alendronate Sodium | ALENDRONATE SODIUM | Aurobindo Pharma Limited | 815a87c4-e489-4eb9-9a2e-fb7a16642f01 | 2026-05-21 | Warnings, Adverse reactions | ANDA090124 904396 904431 904419 2UY4M2U3RA |
| Caldesene Baby | STARCH, CORN AND ZINC OXIDE | Insight Pharmaceuticals LLC | 9f12dee2-7afa-45e9-a729-0fd42bb77715 | 2026-04-22 | Warnings | O8232NY3SJ |
| Caldesene Medicated Protecting | CORNSTARCH AND ZINC OXIDE | Insight Pharmaceuticals LLC | ffc92a0f-a7cf-4a46-b2f1-089df2bbb96b | 2026-04-22 | Warnings | O8232NY3SJ |
| ALENDRONATE SODIUM | ALENDRONATE SODIUM | Cipla USA Inc. | e2fac28d-ad91-4cdc-a003-9fdeac073f76 | 2026-03-25 | Warnings, Adverse reactions | 904396 904431 2UY4M2U3RA |
| FOSAMAX | ALENDRONATE SODIUM | Organon LLC | 14e931fd-2c5f-4d90-b7db-5980706f4a56 | 2026-03-12 | Warnings, Adverse reactions | 904431 2UY4M2U3RA |
| ALENDRONATE SODIUM | ALENDRONATE SODIUM | Preferred Pharmaceuticals Inc. | 83e3ba94-d882-4b5c-87cb-af1eb0997efc | 2026-02-16 | Warnings, Adverse reactions | 904431 2UY4M2U3RA |
| Alendronate Sodium | ALENDRONATE SODIUM | A-S Medication Solutions | eeb65442-6b3c-485c-9c5d-9cf40df4451e | 2026-02-13 | Warnings, Adverse reactions | ANDA090124 50090-5677-1 50090-5677-0 50090-5677 50090567700 904431 2e465e5f-913b-46e8-b69d-cfca38d04db7 eeb65442-6b3c-485c-9c5d-9cf40df4451e 2UY4M2U3RA |
| Binosto | ALENDRONATE SODIUM | Radius Health, Inc. | 09765234-01bc-40f7-b9bb-c167056f3909 | 2026-02-06 | Warnings, Adverse reactions | 2UY4M2U3RA |
| FOSAMAX PLUS D | ALENDRONATE SODIUM AND CHOLECALCIFEROL | Organon LLC | 10307e7e-9a84-4aa1-8c5c-4b209cffe4d1 | 2026-02-03 | Warnings, Adverse reactions | 2UY4M2U3RA |
| Lotrimin Daily Sweat and Odor Control | TOPICAL STARCH | Bayer HealthCare LLC. | 9ec5c80d-b550-496f-e053-2a95a90a5489 | 2026-01-16 | Warnings | O8232NY3SJ |
| Alendronate Sodium | ALENDRONATE SODIUM | Hikma Pharmaceuticals USA Inc. | c910bb05-279b-4ffa-a867-46f4a0853ed5 | 2026-01-15 | Warnings, Adverse reactions | 2UY4M2U3RA |
| Medicated Cornstarch Baby Powder | ACTIVE CORN STARCH | Davion, Inc. | e39032d1-c8cd-4a41-af10-126970b8ad38 | 2025-12-29 | Warnings | O8232NY3SJ |
| Alendronate | ALENDRONATE SODIUM | Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. | a24fd39c-34a7-4de2-9439-781e612189ca | 2025-12-16 | Warnings, Adverse reactions | 904396 904431 2UY4M2U3RA |
| ALENDRONATE SODIUM | ALENDRONATE SODIUM | A-S Medication Solutions | fe1dd324-eb02-4a73-97f5-9b77a7df10a7 | 2025-12-05 | Warnings, Adverse reactions | 904431 2UY4M2U3RA |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.